Gary Charles Robb - 17 Aug 2026 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Reporting relationship: Chief Business Officer
Issuer ticker: CORT
Reported as of: 17 Aug 2026
Net transaction value: -$1,162,572
SEC form: 4
Accepted by SEC: 18 Aug 2026, 16:30:06 UTC
Prior SEC filing: 14 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Joseph Douglas Lyon, as attorney-in-fact for Gary Charles Robb

Key filing fact

Gary Charles Robb filed Form 4 for CORCEPT THERAPEUTICS INC (CORT) on 18 Aug 2026.

Key facts

This page summarizes Gary Charles Robb's Form 4 filing for CORCEPT THERAPEUTICS INC (CORT).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 18 Aug 2026, 16:30.

Change

Previous filing in this sequence was filed on 14 Aug 2026.
Current net transaction value: -$1,162,572.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001529655 Primary reporting owner

Robb Gary Charles

Relationship: Chief Business Officer
Address: C/O CORCEPT THERAPEUTICS INCORPORATED, 101 REDWOOD SHORES PARKWAY, REDWOOD CITY
Signature: /s/ Joseph Douglas Lyon, as attorney-in-fact for Gary Charles Robb
Signature date: 18 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CORT transaction

Common Stock

Gift

Transaction value
Shares: -125
Change %: -0.92%
Price: $0.000000^*
Shares after: 13,426
Date: 17 Aug 2026
Ownership: Direct
Footnotes: F1

CORT transaction

Common Stock

Sale

Transaction value: $1,162,572
Shares: -10,000
Change %: -20%
Price: $116.26
Shares after: 39,716
Date: 17 Aug 2026
Ownership: Gary Charles Robb TTE Robb Revocable Trust
Footnotes: F2, F3

CORT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 15,571
Date: 17 Aug 2026
Ownership: Custodial Account for Child
Footnotes: F4

CORT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 15,571
Date: 17 Aug 2026
Ownership: Custodial Account for Child
Footnotes: F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Includes 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 776 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Footnote F2

Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $116.00 to $116.54 per share. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.

Footnote F3

These shares are held by Gary Charles Robb TTE Robb Revocable Trust of which the Reporting Person is trustee.

Footnote F4

These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.

Footnote F5

These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.

SEC remarks

The power of attorney under which this form was signed is on file with the Commission.